To assess whether treatment with NovoSeven , a recombinant activated FVII ( rFVIIa ) , could improve coagulation function and therefore reduce blood loss , blood transfusion and all-cause mortality during necrosectomy in patients with infected necrosis secondary to severe acute pancreatitis .